Search research articles
Contact Us
Filters
Showing results (121-130 of 244) with videos related to
Page
of 25
Sort By:
Leukemia
|
November 5, 2004
Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation
M Mohty, D Blaise, C Faucher, et al.
Blood
|
December 1, 1991
Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia
M F Bertheas, M Lafage, P Levy, et al.
Anti-Cancer Drugs
|
June 23, 1999
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma
G Gravis, F Pech-Gourgh, P Viens, et al.
Anticancer Research
|
April 9, 2005
High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study
A Gonçalves, A C Braud, F Viret, et al.
Presse Medicale (Paris, France : 1983)
|
January 21, 1995
[Sarcoma of the aortic intima: a rare cause of arterial embolism]
F Bertucci, D Baume, P Viens, et al.
Anticancer Research
|
August 21, 2003
Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors
A Gonçalves, A C Braud, F Viret, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2
D Olive, M Lopez, D Blaise, et al.
Bone Marrow Transplantation
|
March 7, 1998
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome
P Viens, F Penault-Llorca, J Jacquemier, et al.
Gynecologic Oncology
|
November 6, 2007
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
A Goncalves, M Fabbro, C Lhommé, et al.
Anticancer Research
|
December 17, 1998
rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: response and enhancement of further chemosensitivity
G Gravis, P Viens, R Delva, et al.
Page
of 25
Search research articles
Search
Showing results (121-130 of 244) with videos related to
Sort By:
Page
of 25
Leukemia
|
November 5, 2004
Impact of plasmacytoid dendritic cells on outcome after reduced-intensity conditioning allogeneic stem cell transplantation
M Mohty, D Blaise, C Faucher, et al.
Blood
|
December 1, 1991
Influence of mixed chimerism on the results of allogeneic bone marrow transplantation for leukemia
M F Bertheas, M Lafage, P Levy, et al.
Anti-Cancer Drugs
|
June 23, 1999
Phase II study of a combination of low-dose cisplatin with 13-cis-retinoic acid and interferon-alpha in patients with advanced head and neck squamous cell carcinoma
G Gravis, F Pech-Gourgh, P Viens, et al.
Anticancer Research
|
April 9, 2005
High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study
A Gonçalves, A C Braud, F Viret, et al.
Presse Medicale (Paris, France : 1983)
|
January 21, 1995
[Sarcoma of the aortic intima: a rare cause of arterial embolism]
F Bertucci, D Baume, P Viens, et al.
Anticancer Research
|
August 21, 2003
Phase I study of pegylated liposomal doxorubicin (Caelyx) in combination with carboplatin in patients with advanced solid tumors
A Gonçalves, A C Braud, F Viret, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
December 1, 1991
Cell surface expression of ICAM-1 (CD54) and LFA-3 (CD58), two adhesion molecules, is up-regulated on bone marrow leukemic blasts after in vivo administration of high-dose recombinant interleukin-2
D Olive, M Lopez, D Blaise, et al.
Bone Marrow Transplantation
|
March 7, 1998
High-dose chemotherapy and haematopoietic stem cell transplantation for inflammatory breast cancer: pathologic response and outcome
P Viens, F Penault-Llorca, J Jacquemier, et al.
Gynecologic Oncology
|
November 6, 2007
A phase II trial to evaluate gefitinib as second- or third-line treatment in patients with recurring locoregionally advanced or metastatic cervical cancer
A Goncalves, M Fabbro, C Lhommé, et al.
Anticancer Research
|
December 17, 1998
rIL-2 in metastatic soft tissue sarcomas refractory to chemotherapy: response and enhancement of further chemosensitivity
G Gravis, P Viens, R Delva, et al.
Page
of 25